APA (7th ed.) Citation

S, S., N, K., H, H., Y, T., K, T., K, K., . . . H, I. (2023). Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer. Breast cancer research and treatment, 202(3), 473. https://doi.org/10.1007/s10549-023-07097-6

Chicago Style (17th ed.) Citation

S, Sasada, et al. "Prognostic Impact of Adjuvant Endocrine Therapy for Estrogen Receptor-positive and HER2-negative T1a/bN0M0 Breast Cancer." Breast Cancer Research and Treatment 202, no. 3 (2023): 473. https://doi.org/10.1007/s10549-023-07097-6.

MLA (9th ed.) Citation

S, Sasada, et al. "Prognostic Impact of Adjuvant Endocrine Therapy for Estrogen Receptor-positive and HER2-negative T1a/bN0M0 Breast Cancer." Breast Cancer Research and Treatment, vol. 202, no. 3, 2023, p. 473, https://doi.org/10.1007/s10549-023-07097-6.